VX-787 Pimodivir
- 公司名稱 MedChemExpress LLC
- 品牌 MedChemExpress (MCE)
- 型號(hào) VX-787
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2019/6/27 9:09:58
- 訪問(wèn)次數(shù) 584
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息,謝謝!
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 10 mM * 1 mL;2 mg;5 mg;10 mg;25 mg;50 mg |
---|---|---|---|
貨號(hào) | HY-12353A | 應(yīng)用領(lǐng)域 | 生物產(chǎn)業(yè) |
Pimodivir
產(chǎn)品活性:Pimodivir (VX-787) 是一種可口服的甲型流感病毒聚合酶抑制劑,通過(guò)抑制PB2亞基起作用。
研究領(lǐng)域:Anti-infection
作用靶點(diǎn):Influenza Virus
In Vitro: Pimodivir rescues macrophages from virus-mediated death at non-cytotoxic concentrations 24 hpi. The EC50 value for Pimodivir are 8 and 12 nM for A(H1N1) and A(H3N2) strains, respectively, whereas the CC50 values are >1 μM, giving selectivity indexes (SI) > 125 and > 83 for A(H1N1) and A(H3N2) strains, respectively. Pimodivir significantly attenuates the transcription of viral M1 RNA in macrophages, which are infected with A(H1N1) or A(H3N2) strains for 8 h. Pimodivir inhibits the transcription of viral but not cellular genes. Pimodivir allows some activation of IAV-mediated expression of several cellular genes, which are involved in tryptophan and nucleotide metabolism. Pimodivir possesses excellent anti-IAV but not immuno/metabolo-modulating effect. Pimodivir (VX-787) is very potent against influenza A strains, including pandemic 2009 H1N1 and avian H5N1. Pimodivir (VX-787) shows potent activity against all influenza A virus strains tested, with an EC50 range of 0.13 to 3.2 nM. Pimodivir-selected PB2 variant viruses maintain susceptibility to neuraminidase inhibitors in vitro.
In Vivo: Pimodivir (2, 6, and 20 mg/kg/day, p.o.) and oseltamivir (20 mg/kg/day) completely prevent death in the H1N1pdm virus infection in mice. Pimodivir (20 mg/kg/day) is more effective than oseltamivir (20 mg/kg/day) in improving body weight and reducing the severity of lung infection. Moreover, Pimodivir (VX-787) shows * survival in a +48 h delay to treatment mouse influenza model at 10, 3 and 1 mpk (BID × 10 days) whereas the SOC, oseltamivir, provide no survival benefit in this model at 10 mpk. Pimodivir (VX-787; 1, 3, or 10 mg/kg, bid) provided complete survival, with a dose-dependent reduction in BW loss of the mice.
相關(guān)產(chǎn)品:Drug Repurposing Compound Library | Anti-Infection Compound Library | Anti-Virus Compound Library | Clinical Compound Library | Clinical Compound Library Plus | Drug Repurposing Compound Library Plus | Bioactive Compound Library Plus | Oseltamivir acid | Aprotinin | Baloxavir | KIN1148 | Nitazoxanide | Zanamivir | Arbidol hydrochloride | Nucleozin | Theaflavin | Amantadine hydrochloride | RIG-1 modulator 1 | Peramivir trihydrate | Desaminotyrosine | Rimantadine hydrochloride | SP187 | 3,4'-Dihydroxyflavone | Moroxydine hydrochloride | S119-8 | Sodium copper chlorophyllin | CEF1, Influenza Matrix Protein M1 58-66 | Dehydroandrographolide | Influenza A NP(366-374) Strain A/PR/8/35 | Influenza NP 147-155 | M2 ion channel blocker | M2e, human | CEF3